Small-Molecule Inhibitors of Cholesterol Sulfotransferase as Immunomodulatory Agents
ACS Chemical Biology · 28.10.2026
DOI: 10.1021/acschembio.6c00658 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 28.10.2026. Verfasst von Lindsay E Boudreau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Illinois Urbana Champaign, Urbana, IL61801, USA. Die Arbeit nennt 63 Literaturangaben. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Though immune checkpoint blockade (ICB) therapy has been a promising advance in cancer treatment, response rates to ICB are low owing to other mechanisms that cancers employ to evade the immune system. SULT2B1b is an enzyme known to produce cholesterol sulfate (CS), an immunosuppressive metabolite that inhibits T-cell migration. Cancers expressing high levels of SULT2B1b thus generate a tumor microenvironment that excludes T cells, which leads to increased tumor growth and renders ICB therapy ineffective. Here, we identify a novel class of azasteroid SULT2B1b inhibitors with greater potency and selectivity than previously identified compounds. X-ray co-crystal structures indicate that these inhibitors bind in a conformation different from that of native substrates, enabling inhibition without acting as a substrate. Additionally, these new compounds effectively reduce CS levels in tumors in mice and, as such, have potential as cancer therapeutics in combination with ICB therapy.
Autor:innen und Institutionen
- Department of Chemistry, University of Illinois Urbana Champaign, Urbana, IL61801, USA.
- Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana Champaign, Urbana, IL61801, USA.
- Center of Biophysics and Quantitative Biology, University of Illinois Urbana Champaign, Urbana, IL61801, USA.
- Department of Biochemistry, University of Illinois Urbana Champaign, Urbana, IL61801, USA.
- Cancer Center at Illinois, University of Illinois Urbana Champaign, Urbana, IL61801, USA.
ORCID-Profile: Amanda J Smith, Hyang Yeon Lee, Kenneth Chen, Satish K Nair, Paul J Hergenrother
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
- University of Illinois
Zitieren
APA
Boudreau, L. E., Smith, A. J., Lee, H. Y., Chakraborty, B., Abo, K. R., Chen, K., Nair, S. K., & Hergenrother, P. J. (2026). Small-Molecule Inhibitors of Cholesterol Sulfotransferase as Immunomodulatory Agents. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00658
Vancouver
Boudreau LE, Smith AJ, Lee HY, Chakraborty B, Abo KR, Chen K, et al. Small-Molecule Inhibitors of Cholesterol Sulfotransferase as Immunomodulatory Agents. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00658
BibTeX
@article{Boudreau2026,
author = {Boudreau, Lindsay E and Smith, Amanda J and Lee, Hyang Yeon and Chakraborty, Bidisha and Abo, Kyle R and Chen, Kenneth and Nair, Satish K and Hergenrother, Paul J},
title = {Small-Molecule Inhibitors of Cholesterol Sulfotransferase as Immunomodulatory Agents},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00658}
}
EUVIMED